Biblio

Export 3142 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
J. R. Clarke, Ribeiro, F. C., Frozza, R. L., De Felice, F. G., and Lourenco, M. V., “Metabolic Dysfunction in Alzheimer's Disease: From Basic Neurobiology to Clinical Approaches.”, J Alzheimers Dis, vol. 64, no. s1, pp. S405-S426, 2018.
J. J. Claus, Staekenborg, S. S., Roorda, J. J., Stevens, M., Herderschee, D., van Maarschalkerweerd, W., Schuurmans, L., Tielkes, C. E. M., Koster, P., Bavinck, C., and Scheltens, P., “Low Prevalence of Mixed Dementia in a Cohort of 2,000 Elderly Patients in a Memory Clinic Setting.”, J Alzheimers Dis, vol. 50, no. 3, pp. 797-806, 2016.
J. J. Claus, Coenen, M., Staekenborg, S. S., Schuur, J., Tielkes, C. E. M., Koster, P., and Scheltens, P., “Cerebral White Matter Lesions have Low Impact on Cognitive Function in a Large Elderly Memory Clinic Population.”, J Alzheimers Dis, 2018.
F. Clay, Howett, D., Fitzgerald, J., Fletcher, P., Chan, D., and Price, A., “Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 75, no. 1, pp. 23-43, 2020.
E. Galkina Cleary, Cifuentes, M., Grinstein, G., Brugge, D., and Shea, T. B., “Association of Low-Level Ozone with Cognitive Decline in Older Adults.”, J Alzheimers Dis, vol. 61, no. 1, pp. 67-78, 2018.
V. Clemens, Regen, F., Le Bret, N., Heuser, I., and Hellmann-Regen, J., “Retinoic Acid Enhances Apolipoprotein E Synthesis in Human Macrophages.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1295-1300, 2018.
A. Clements-Cortes, Ahonen, H., Evans, M., Freedman, M., and Bartel, L., “Short-Term Effects of Rhythmic Sensory Stimulation in Alzheimer's Disease: An Exploratory Pilot Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 651-60, 2016.
E. N. Cline, Bicca, M. Assunção, Viola, K. L., and Klein, W. L., “The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.”, J Alzheimers Dis, vol. 64, no. s1, pp. S567-S610, 2018.
E. Coart, Barrado, L. García, Duits, F. H., Scheltens, P., van der Flier, W. M., Teunissen, C. E., van der Vies, S. M., and Burzykowski, T., “Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
S. L. Cody, Miller, G. H., Fazeli, P. L., Wang, G., Li, W., Goodin, B. R., and Vance, D. E., “Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research.”, J Alzheimers Dis, vol. 95, no. 3, pp. 753-768, 2023.
I. Cohen-Manheim, Doniger, G. M., Sinnreich, R., Simon, E. S., Murad, H., Pinchas-Mizrachi, R., and Kark, J. D., “Body Mass Index, Height, and Socioeconomic Position in Adolescence, Their Trajectories into Adulthood, and Cognitive Function in Midlife.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1207-1221, 2017.
J. Colin, Allouche, A., Chauveau, F., Corbier, C., Pauron-Gregory, L., Lanhers, M. - C., Claudepierre, T., Yen, F. T., Oster, T., and Malaplate-Armand, C., “Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide.”, J Alzheimers Dis, vol. 52, no. 3, pp. 975-87, 2016.
J. L. Conde-Sala, Turró-Garriga, O., Portellano-Ortiz, C., Viñas-Diez, V., Gascón-Bayarri, J., and Reñé-Ramírez, R., “Self-Perceived Quality of Life Among Patients with Alzheimer's Disease: Two Longitudinal Models of Analysis.”, J Alzheimers Dis, vol. 52, no. 3, pp. 999-1012, 2016.
C. Conejero-Goldberg, Hyde, T. M., Chen, S., Herman, M. M., Kleinman, J. E., Davies, P., and Goldberg, T. E., “Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration.”, J Alzheimers Dis, 2015.
S. C. Conner, Benayoun, L., Himali, J. J., Adams, S. L., Yang, Q., DeCarli, C., Blusztajn, J. K., Beiser, A., Seshadri, S., and Delalle, I., “Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.”, J Alzheimers Dis, vol. 68, no. 1, pp. 357-365, 2019.
M. H. Connors, Ames, D., Boundy, K., Clarnette, R., Kurrle, S., Mander, A., Ward, J., Woodward, M., and Brodaty, H., “Mortality in Mild Cognitive Impairment: A Longitudinal Study in Memory Clinics.”, J Alzheimers Dis, vol. 54, no. 1, pp. 149-55, 2016.
M. H. Connors, Ames, D., Boundy, K., Clarnette, R., Kurrle, S., Mander, A., Ward, J., Woodward, M., and Brodaty, H., “Predictors of Mortality in Dementia: The PRIME Study.”, J Alzheimers Dis, vol. 52, no. 3, pp. 967-74, 2016.
C. Contini, Serrao, S., Manconi, B., Olianas, A., Iavarone, F., Bizzarro, A., Masullo, C., Castagnola, M., Messana, I., Diaz, G., and Cabras, T., “Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.”, J Alzheimers Dis, vol. 89, no. 2, pp. 605-622, 2022.
E. Marina Gon Cordero, Cuevas-Budhart, M. Angel, Morán, D. Pérez, Villeda, M. Angel Trej, and Gª-Madrid, M. Gomez- Del-, “Relationship Between the Gut Microbiota and Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 87, no. 2, pp. 519-528, 2022.
R. R. Corrigan, Labrador, L., Grizzanti, J., Mey, M., Piontkivska, H., and Casadesus-Smith, G., “Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1495-1514, 2023.
N. Cortés, Andrade, V., and Maccioni, R. B., “Behavioral and Neuropsychiatric Disorders in Alzheimer's Disease.”, J Alzheimers Dis, 2018.
A. Corvol, Netter, A., Campeon, A., and Somme, D., “Implementation of an Occupational Therapy Program for Alzheimer's Disease Patients in France: Patients' and Caregivers' Perspectives.”, J Alzheimers Dis, vol. 62, no. 1, pp. 157-164, 2018.
S. Cosentino, Devanand, D., and Gurland, B., “A Link between Subjective Perceptions of Memory and Physical Function: Implications for Subjective Cognitive Decline.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1387-1398, 2018.
P. Coskun, Helguera, P., Nemati, Z., Bohannan, R. C., Thomas, J., Samuel, S. E., Argueta, J., Doran, E., Wallace, D. C., Lott, I. T., and Busciglio, J., “Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 737-748, 2017.
M. Costa, Horrillo, R., Ortiz, A. María, Pérez, A., Mestre, A., Ruiz, A., Boada, M., and Grancha, S., “Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1395-1404, 2018.

Pages